The authors indicate that this treatment represents a paradigm shift in the treatment of the disease. The study concluded that the patients not only improved their lung function, but also had fewer attacks. A study of patients with asthma performed by researchers from Rutgers University and an international team revealed that a combination of two drugs, albuterol and the budesonide drastically reduces the chances of experiencing an asthma attack. The results of the clinical trial, published in The New England Journal of Medicine confirm that a combination of albuterol, which provides relief from an asthma attack by relaxing smooth muscle and is used for immediate relief of asthma, and the corticosteroid budesonide, administered by inhaler, reduces the number of exacerbations, which can cause often a visit to the emergency room, hospitalization or, in some cases, death. To read the full story.